Philip Silverman serves as VP, Corporate Development and Board Member for Akava Therapeutics, Inc. He helped his father, Dr. Richard Silverman, start the company in 2019 and currently focuses on strategic and business-related matters, which include overseeing budgets, hiring key employees, managing investor relations, interacting with the legal team, and advising on any major strategic decisions. In addition to his role at Akava, Philip is also Co-CEO of Bricks Capital where he oversees the functioning of his family office. Philip holds a BBA from the University of Michigan Ross School of Business.